Slideshow

Traditional CV Risk Models May Fall Short in Lupus

While traditional risk factors play a role, factors specific to SLE also contribute to CVD.

Related Videos
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
Related Content
Cell Therapies Hope to be Next Frontier for Alzheimer Disease
October 4th 2024

Faster Weight Loss on Anti-Obesity Medication Correlated With Lower Risk of Gout

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
Early Rheumatoid Arthritis Characteristics Have Changed Over Last 20 Years
October 3rd 2024

Early Rheumatoid Arthritis Characteristics Have Changed Over Last 20 Years

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
M. Elaine Husni, MD, MPH, Vice Chair of Rheumatology, and Director, Arthritis and Musculoskeletal Center, and Staff Physician, Orthopedic and Rheumatologic Institute, Cleveland Clinic, and Assistant Professor, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Published: October 2nd 2024 | Updated: October 2nd 2024

Bimekizumab Improves Pain, Fatigue, and More in Active Psoriatic Arthritis Over Placebo

Victoria Johnson
Service Members Fail to Receive Suitable Follow-up Care for Fibromyalgia
October 1st 2024

Service Members Often Fail to Receive Suitable Follow-up Care for Fibromyalgia

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.